Amgen To Present At The Evercore ISI Virtual HealthCONx Conference

Rhea-AI Summary

Amgen (NASDAQ:AMGN) is set to present at the Evercore ISI Virtual HealthCONx Conference on Dec. 1, 2020, at 1:50 p.m. ET. Key executives, including David M. Reese and Peter H. Griffith, will lead the presentation. Interested parties can access the live audio on Amgen's website under the Events Calendar, with a replay available for 90 days. Amgen is focused on innovative therapeutics and addressing unmet medical needs, aiming to improve health outcomes globally. More details can be found at www.amgen.com.

News Market Reaction – AMGN

+2.04%

+2.04% Session move

In the trading session that priced this news, AMGN gained 2.04%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., Nov. 25, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Evercore ISI Virtual HealthCONx Conference at 1:50 p.m. ET on Tuesday, Dec. 1, 2020. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631 (media) 
Arvind Sood, 805-447-1060 (investors) 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-evercore-isi-virtual-healthconx-conference-301180785.html

SOURCE Amgen

FAQ

What time will Amgen present at the Evercore ISI Virtual HealthCONx Conference?

Amgen will present at the conference on Dec. 1, 2020, at 1:50 p.m. ET.

Who from Amgen will present at the conference?

David M. Reese and Peter H. Griffith from Amgen will present at the conference.

How can I access the Amgen conference presentation?

The live audio of the presentation can be accessed on Amgen's website under the Events Calendar.

Will there be a replay of the Amgen conference presentation?

Yes, a replay of the presentation will be available on Amgen's website for at least 90 days following the event.

What is Amgen's focus as a biotechnology company?

Amgen focuses on discovering and delivering innovative human therapeutics, addressing areas of high unmet medical need.